Larry Lin is a seasoned business development and licensing executive in the pharmaceutical and biotechnology industries. They have held significant roles at major companies, including serving as the Head of Worldwide BD Asia and Neurosciences at GlaxoSmithKline since 2013 and as the Head of Innovation Hub BD & Licensing Asia Pacific at Merck since 2015. Larry's career also includes positions such as Director of Open Innovation, Asia Pacific at Johnson & Johnson and Director of Business Development at Amgen Inc. They obtained an MBA from the Massachusetts Institute of Technology - Sloan School of Management and hold a Ph.D. from Yale University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices